Indapamide retard as the medication of choice in elderly patients with arterial hypertension

Чукаева, И. И.; Спирякина, Я. Г.

doi:10.15829/1560-4071-2013-5-56-60

Russ J Cardiol

2013

DOI: 10.15829/1560-4071-2013-5-56-60

|View full text |Cite

Indapamide retard as the medication of choice in elderly patients with arterial hypertension

И. И. Чукаева¹,

Я. Г. Спирякина²

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2019

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension

Гороховская¹,

IuN²,

Мартынов³

et al. 2019

Medicinskij sovet

View full text Add to dashboard Cite

Despite our achievements in modern medicine, arterial hypertension (AH) remains one of the main causes of fatal complications, such as myocardial infarction and acute cerebrovascular accident leading to disability and mortality of patients, including those of working age. The prevalence of hypertension is significantly higher among old and senile age population, however, it has recently tended to increase in young and middle-aged people. Thus, the Russian epidemiological ESSE-RF study, in which representative sample of the Russian population aged 25–64 years were studied, showed that the prevalence of hypertension in individuals of that age group was 44%. It was predicted that the world’s burden of hypertension would increase by 15–20% to approximately 1.5 million people in the year 2015. Due to the high incidence of hypertension and complications associated with hypertension development, further study of pathogenetic mechanisms, development of diagnostic examination methods, prophylactic measures and the search for new treatment options with fixed-dose combination drugs is an important area of modern medicine. This article provides an overview of clinical studies of the components (lisinopril and indapamide) of a rational ACE inhibitor–diuretic combination and a clinical example.

show abstract

Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension

Гороховская¹,

IuN²,

Мартынов³

et al. 2019

Medicinskij sovet

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Indapamide retard as the medication of choice in elderly patients with arterial hypertension

Cited by 1 publication

References 13 publications

Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension

Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension

Contact Info

Product

Resources

About